The Phase one clinical trial of indigenously developed vaccine Covaxin for Covid-19 is underway in Nagpur in Maharashtra. Hyderabad based Bharat Biotech developed a vaccine for Coronavirus has been administered on 55 volunteers and nobody has reported complications so far and the company is planning to start its second phase from 10th of August.  <br />''<br />''The clinical trial of Covaxin is being conducted at Nagpur's Gillurkar hospital. The trial which began on 27th of July has completed 11 days now.<br />''<br />''Director of the hospital Dr. Chandrashekhar Gillurkar said three milligram intra-muscular dose was given to each volunteer over a period of time and no case of reaction was reported so far. The hospital has achieved a unique feat as it ranks second in conducting clinical trials of this vaccine developed by the Hyderabad based company.<br />''<br />''PGI Rohtak ranks first as it has conducted trials on 80 volunteers. Dr.  Gillurkar said, a 20 year old youth and two others will be given a second dose of this vaccine on 10th of August. Likewise, they will be vaccinated after a gap of 28 days, 42 days, 104 days and 194th day. After each dose the blood sample of these volunteers will be collected to check the anti-bodies present in them. <br />